SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001650664-23-000005
Filing Date
2023-10-10
Accepted
2023-10-10 16:05:18
Documents
12
Period of Report
2023-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K edit-20231003.htm   iXBRL 8-K 28039
  Complete submission text file 0001650664-23-000005.txt   153362

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20231003.xsd EX-101.SCH 1922
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20231003_lab.xml EX-101.LAB 23834
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20231003_pre.xml EX-101.PRE 12522
6 EXTRACTED XBRL INSTANCE DOCUMENT edit-20231003_htm.xml XML 2714
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 231317966
SIC: 2836 Biological Products, (No Diagnostic Substances)